Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief R&D Officer

President & CEO

Chief Legal Officer

Chief Commercial Officer

Chief Financial Officer

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor for complement-mediated diseases; and Galidesivir, to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-31	Premium	sold (taxes)	Premium	Premium	Premium	Chief R&D Officer
2024-02-29	Premium	acquired	Premium	Premium	Premium	-
2024-02-29	Premium	acquired	Premium	Premium	Premium	-
2024-01-03	Premium	gifted	Premium	Premium	Premium	President & CEO
2024-01-03	Premium	gifted	Premium	Premium	Premium	President & CEO
2023-12-19	Premium	sold (taxes)	Premium	Premium	Premium	Chief Legal Officer
2023-12-19	Premium	sold (taxes)	Premium	Premium	Premium	President & CEO
2023-12-19	Premium	sold (taxes)	Premium	Premium	Premium	Chief Commercial Officer
2023-12-19	Premium	sold (taxes)	Premium	Premium	Premium	Chief R&D Officer
2023-12-19	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-12-14	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-12-14	Premium	sold (taxes)	Premium	Premium	Premium	Chief Legal Officer
2023-12-14	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-12-14	Premium	sold (taxes)	Premium	Premium	Premium	Chief Commercial Officer
2023-12-14	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2023-12-14	Premium	sold (taxes)	Premium	Premium	Premium	President & CEO
2023-12-14	Premium	acquired	Premium	Premium	Premium	Chief R&D Officer
2023-12-14	Premium	acquired	Premium	Premium	Premium	President & CEO
2023-12-14	Premium	sold (taxes)	Premium	Premium	Premium	Chief R&D Officer
2023-12-14	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-11-30	Premium	acquired	Premium	Premium	Premium	-
2023-11-30	Premium	acquired	Premium	Premium	Premium	-
2023-08-31	Premium	acquired	Premium	Premium	Premium	-
2023-08-31	Premium	acquired	Premium	Premium	Premium	-

BCRX - BioCryst Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for BCRX